The expression of BCL9/BCL9L negatively related to the infiltration of CD8+ T cells in triple negative breast cancer, and BCL9/BCL9L inhibited the infiltration of CD8+ T cells in the tumor microenvironment [45]. This evidence concerns the gene CD8A and neoplasm.